Organization
BCCA
10 abstracts
Abstract
Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors.Org: BCCA,
Abstract
Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors.Org: BC Cancer-Vancouver Centre, BC Cancer, Vancouver, BC Cancer, Abbotsford, BC Cancer Agency Vancouver Island Centre, BCCA,
Abstract
A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).Org: Juravinski Cancer Inst, BCCA, Sindi Ahluwalia Hawkins Centre for the Southern Interior, Princess Margaret - University Health Network, Juravinski Cancer Centre, McMaster University,
Abstract
Prospective evaluation of the utility of concurrent 18F-FDG PET/CT and 68Ga-DOTA-TOC imaging in gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): The PETNET study.Org: BC Cancer-Vancouver Centre, Vancouver Cancer Centre, BC Cancer Research Institute, BCCA,
Abstract
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.Org: BCCA, Princess Margaret - University Health Network, Saskatchewan Health Authority, Centre hospitalier de l'Université de Montréal, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada,
Abstract
CfDNA NGS detection of fusions acquired as mechanisms of resistance in the post-EGFR setting across multiple solid tumors.Org: Guardant Health Inc., Palo Alto University, CanSino Biologics, Guardant Health, Inc., Redwood City, CA,
Abstract
Correlating expression of NaPi2b and FRa in high grade serous ovarian cancer (HGSOC).Org: Sarah Cannon Research Institute/Tennessee Oncology, Mary Crowley Cancer Research Center, Tennessee Oncology, PLLC, BCCA, Sindi Ahluwalia Hawkins Centre for the Southern Interior,
Abstract
Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial.Org: BC Cancer-Vancouver Centre, Pancreas Centre BC, Canadian Cancer Trials Group, Queen's University, Belfast, Providence Cancer Institute,
Abstract
Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.Org: University of Texas MD Anderson Cancer Center, The University of Pittsburgh, NRG Oncology SDMC, NSABP Foundation, Inc., UMPC Hillman Cancer Center,
Abstract
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: A cost consequence analysis using linked administrative data.Org: Princess Margaret Cancer Centre, Institute for Clinical Evaluative Sciences, University Health Network, Sunnybrook Health Sciences Centre, Odette Cancer Centre,